Gene Therapies

Boosting Yield and Preserving Quality: Increasing Production of Induced Pluripotent Stem Cells for Cell Therapy and Regenerative Medicine Applications
Gene Therapies
Boosting Yield and Preserving Quality: Increasing Production of Induced Pluripotent Stem Cells for Cell Therapy and Regenerative Medicine ApplicationsBoosting Yield and Preserving Quality: Increasing Production of Induced Pluripotent Stem Cells for Cell Therapy and Regenerative Medicine Applications

byBrian Gazaille, Maxime Feyeux
Mar 16, 2022
Realization of Quality By Design and Beyond: The Intelligent Cell Processing System
Sponsored Content
Realization of Quality By Design and Beyond: The Intelligent Cell Processing SystemRealization of Quality By Design and Beyond: The Intelligent Cell Processing System
byMasaki Hosoya, Tsutomu Somaand 1 more
Dec 14, 2021
Get High-Throughput, Definitive Identification of Viable Cells and More in Your Cell Therapy
Sponsored Content
Get High-Throughput, Definitive Identification of Viable Cells and More in Your Cell TherapyGet High-Throughput, Definitive Identification of Viable Cells and More in Your Cell Therapy
byAdam Ross, Bernardo Cordovezand 1 more
Dec 10, 2021
Addressing Critical Issues in Cell and Gene Therapy Manufacturing
Sponsored Content
Addressing Critical Issues in Cell and Gene Therapy ManufacturingAddressing Critical Issues in Cell and Gene Therapy Manufacturing
byJosh Snow
Dec 10, 2021
Reducing Cell and Gene Therapy Development Time and Cost with New Purification Strategies
Sponsored Content
Reducing Cell and Gene Therapy Development Time and Cost with New Purification StrategiesReducing Cell and Gene Therapy Development Time and Cost with New Purification Strategies
byDaniella Steel
Dec 8, 2021
eBook: Cell and Gene Therapies — Optimization Strategies for Processing and Potency
Cell Therapies
eBook: Cell and Gene Therapies — Optimization Strategies for Processing and PotencyeBook: Cell and Gene Therapies — Optimization Strategies for Processing and Potency
byMaribel Rios
Nov 19, 2021
Optimizing the AAV Transfection Process in Suspension Cells
Cell Therapies
Optimizing the AAV Transfection Process in Suspension Cells
Optimizing the AAV Transfection Process in Suspension Cells
Oct 29, 2021
byMatthias Hebben, Alengo Nyamay'antu
Viral Safety of Viral Vectors:<br> Special Concerns Arise When the Virus Is the Product
Viral Clearance
Viral Safety of Viral Vectors: Special Concerns Arise When the Virus Is the Product
Viral Safety of Viral Vectors: Special Concerns Arise When the Virus Is the Product
Oct 29, 2021
byCheryl Scott, Hazel Aranha
Formulation, Fill and Finish of Lentiviral Vectors: Part 1 &mdash; Case Study in Facility and Process Design
Facility Design/Engineering
Formulation, Fill and Finish of Lentiviral Vectors: Part 1 — Case Study in Facility and Process Design
Formulation, Fill and Finish of Lentiviral Vectors: Part 1 — Case Study in Facility and Process Design
Oct 29, 2021
byLeslie Southam, James L. Drinkwater
Spurring on Innovation in Gene Therapy Development logo in a gray background | Spurring on Innovation in Gene Therapy Development
Sponsored Content
Spurring on Innovation in Gene Therapy Development
Spurring on Innovation in Gene Therapy Development
Oct 29, 2021
+1
byBrian Gazaille, Roland W. Herzogand 1 more
Transfection Best Practices for AAV Gene Therapy Programs
Sponsored Content
Transfection Best Practices for AAV Gene Therapy Programs
Transfection Best Practices for AAV Gene Therapy Programs
Oct 28, 2021
+1
byAnn Rossi Bilodeau, Alengo Nyamay'antuand 1 more
Focusing on the Patient Journey Can Increase Access to Lifesaving Therapies logo in a gray background | Focusing on the Patient Journey Can Increase Access to Lifesaving Therapies
Economics
Focusing on the Patient Journey Can Increase Access to Lifesaving Therapies
Focusing on the Patient Journey Can Increase Access to Lifesaving Therapies
Oct 28, 2021
byAntoinette Gawin
Recombinant Proteins for Cell and Gene Therapy Research: A Conversation with Shenandoah Biotechnology
Sponsored Content
Recombinant Proteins for Cell and Gene Therapy Research: A Conversation with Shenandoah Biotechnology
Recombinant Proteins for Cell and Gene Therapy Research: A Conversation with Shenandoah Biotechnology
Oct 20, 2021
byBPI Contributor, Pamela De Lacy
eBook: CAR-T Cell Therapy &mdash; Mitigating Clinical and Bioprocess Limitations
Cell Therapies
eBook: CAR-T Cell Therapy — Mitigating Clinical and Bioprocess Limitations
eBook: CAR-T Cell Therapy — Mitigating Clinical and Bioprocess Limitations
Sep 30, 2021
+1
byBrian Gazaille, Cokey Nguyenand 1 more
Strategizing Scale-Up and Scale-Out for Cell Therapy Production
Sponsored Content
Strategizing Scale-Up and Scale-Out for Cell Therapy Production
Strategizing Scale-Up and Scale-Out for Cell Therapy Production
Sep 30, 2021
byChris Suarez
Ask the Expert: Streamlining Mesenchymal Stem Cell Production &mdash; From Expansion Through Removal of Cryoprotectant logo in a gray background | Ask the Expert: Streamlining Mesenchymal Stem Cell Production &mdash; From Expansion Through Removal of Cryoprotectant
Sponsored Content
Ask the Expert: Streamlining Mesenchymal Stem Cell Production — From Expansion Through Removal of Cryoprotectant
Ask the Expert: Streamlining Mesenchymal Stem Cell Production — From Expansion Through Removal of Cryoprotectant
Sep 29, 2021
byBPI Contributor
Corning X-WASH System: DMSO Reduction of Cryopreserved Human Mesenchymal Stem Cells
Sponsored Content
Corning X-WASH System: DMSO Reduction of Cryopreserved Human Mesenchymal Stem Cells
Corning X-WASH System: DMSO Reduction of Cryopreserved Human Mesenchymal Stem Cells
Aug 27, 2021
byHilary Sherman
Accelerating the Development of Cell and Gene Therapies: From Discovery to Biomanufacture
Sponsored Content
Accelerating the Development of Cell and Gene Therapies: From Discovery to Biomanufacture
Accelerating the Development of Cell and Gene Therapies: From Discovery to Biomanufacture
Aug 27, 2021
bySophie Lutter
Autologous CAR T Cell Manufacturing Using a Semiautomatic, Closed, Modular Workflow: Seamless Transition from Discovery to Clinical Manufacturing
Sponsored Content
Autologous CAR T Cell Manufacturing Using a Semiautomatic, Closed, Modular Workflow: Seamless Transition from Discovery to Clinical Manufacturing
Autologous CAR T Cell Manufacturing Using a Semiautomatic, Closed, Modular Workflow: Seamless Transition from Discovery to Clinical Manufacturing
Aug 27, 2021
bySean Chang
eBook: Cell and Gene Therapies &mdash; <br>A 2021 Industry Update
Therapeutic Class
eBook: Cell and Gene Therapies — A 2021 Industry Update
eBook: Cell and Gene Therapies — A 2021 Industry Update
Aug 25, 2021
+2
byDan Stanton, Gareth Macdonaldand 2 more
Raw Materials for Advanced Therapies: When the Process Is the Product, Ingredients Are Key
Cell Therapies
Raw Materials for Advanced Therapies: When the Process Is the Product, Ingredients Are Key
Raw Materials for Advanced Therapies: When the Process Is the Product, Ingredients Are Key
Jun 18, 2021
+1
byBrian Gazaille, Bill Janssenand 1 more
Four Design Factors Shaping Multimodal Cell and Gene Manufacturing
Facility Design/Engineering
Four Design Factors Shaping Multimodal Cell and Gene Manufacturing
Four Design Factors Shaping Multimodal Cell and Gene Manufacturing
Jun 18, 2021
byPeter Walters, Noel Maestre
Measuring Viral Titer in AAV-Mediated Gene Therapy Using a PCR Technique for Absolute Quantitation
Process Development
Measuring Viral Titer in AAV-Mediated Gene Therapy Using a PCR Technique for Absolute Quantitation
Measuring Viral Titer in AAV-Mediated Gene Therapy Using a PCR Technique for Absolute Quantitation
Jun 18, 2021
byDavid Dobnik
Analytical Methods for Cell Therapies: Method Development and Validation Challenges
Product Characterization
Analytical Methods for Cell Therapies: Method Development and Validation Challenges
Analytical Methods for Cell Therapies: Method Development and Validation Challenges
Jun 18, 2021
byRuti Goldberg
A Complete Solution for MSC Therapy Workflows: Cell Scale-Up, Cryopreservation, and DMSO Removal
Sponsored Content
A Complete Solution for MSC Therapy Workflows: Cell Scale-Up, Cryopreservation, and DMSO Removal
A Complete Solution for MSC Therapy Workflows: Cell Scale-Up, Cryopreservation, and DMSO Removal
Jun 18, 2021
byHilary Sherman, Chris Suarez
Overcoming Obstacles in AAV Viral Vector Manufacturing
Sponsored Content
Overcoming Obstacles in AAV Viral Vector Manufacturing
Overcoming Obstacles in AAV Viral Vector Manufacturing
Jun 18, 2021
byEmmanuelle Cameau
Facilities for Novel Therapies: Demystifying Design and Engineering Requirements for Cell and Gene Therapy Production
Facility Design/Engineering
Facilities for Novel Therapies: Demystifying Design and Engineering Requirements for Cell and Gene Therapy Production
Facilities for Novel Therapies: Demystifying Design and Engineering Requirements for Cell and Gene Therapy Production
May 21, 2021
bySue Cooke
Ask the Expert: Formulation Strategies for AAV-Based Gene Therapies logo in a gray background | Ask the Expert: Formulation Strategies for AAV-Based Gene Therapies
Sponsored Content
Ask the Expert: Formulation Strategies for AAV-Based Gene Therapies
Ask the Expert: Formulation Strategies for AAV-Based Gene Therapies
May 21, 2021
byBPI Contributor
Preparing for Process Improvements: Discussions of the Cell Therapy Industry’s Supply Chain, Automation, and Control Needs
Cell Therapies
Preparing for Process Improvements: Discussions of the Cell Therapy Industry’s Supply Chain, Automation, and Control Needs
Preparing for Process Improvements: Discussions of the Cell Therapy Industry’s Supply Chain, Automation, and Control Needs
Apr 26, 2021
byMaribel Rios, Brian Gazaille
The Difficulties of Manufacturing Cell and Gene Therapies At Scale
Cell Therapies
The Difficulties of Manufacturing Cell and Gene Therapies At Scale
The Difficulties of Manufacturing Cell and Gene Therapies At Scale
Apr 26, 2021
byAllan Bream, Brita Salzmann
Manufacture and Regulation of Cell, Gene, and Tissue Therapies: Part 2 &mdash; Regulatory Guidances
Regulatory Affairs
Manufacture and Regulation of Cell, Gene, and Tissue Therapies: Part 2 — Regulatory Guidances
Manufacture and Regulation of Cell, Gene, and Tissue Therapies: Part 2 — Regulatory Guidances
Apr 26, 2021
+2
byAnjali Apte, Adeyemi Afuwapeand 2 more
Viral Clearance in a Downstream AAV Process: Case Study Using a Model Virus Panel and a Noninfectious Surrogate
Viral Clearance
Viral Clearance in a Downstream AAV Process: Case Study Using a Model Virus Panel and a Noninfectious Surrogate
Viral Clearance in a Downstream AAV Process: Case Study Using a Model Virus Panel and a Noninfectious Surrogate
Apr 16, 2021
+12
byMichael Winkler, Mikhail Goldfarband 12 more
Rapid Development of Viral Vector Production Processes: Iterative Parameter Optimization
Sponsored Content
Rapid Development of Viral Vector Production Processes: Iterative Parameter Optimization
Rapid Development of Viral Vector Production Processes: Iterative Parameter Optimization
Apr 16, 2021
+1
byJakub Krakowiak, Qian Liuand 1 more
Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring
PAT
Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring
Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring
Mar 9, 2021
byMason A. Chilmonczyk, Andrei G. Fedorov
Streamlining Industrial Purification of Adeno-Associated Virus
Separation/Purification
Streamlining Industrial Purification of Adeno-Associated Virus
Streamlining Industrial Purification of Adeno-Associated Virus
Dec 17, 2020
+2
byPete Gagnon, Maja Leskovecand 2 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024